Put to the Test: What a Calf Challenge Study Tells Us About Crypto Guard® Calf Protection

When it comes to managing Cryptosporidium in young calves, there are plenty of products and approaches to choose from.
But there's an important question worth asking: Has it actually been put to the test against Crypto?
Crypto Guard® has.
In a controlled calf challenge study, 44 newborn calves were randomly assigned to receive either Crypto Guard or a placebo. Researchers were blinded to which calves received which product. Both were administered orally in milk replacer during the first seven days of life.
Then, at 10 days old, every calf was deliberately challenged with Cryptosporidium parvum. Researchers followed the calves for diarrhea, oocyst shedding, weight gain, and mortality.
The study provides valuable insight into Crypto Guard calf protection against C. parvum.
What Happened After the Challenge?
The differences were measurable.
Calves receiving Crypto Guard had statistically significantly lower levels of diarrhea post-challenge. They also had statistically significantly lower incidence and levels of oocyst shedding, and higher average daily weight gains during the 14-day post-challenge observation period.
In addition, three calves receiving placebo died post-challenge due to the Crypto challenge, while all Crypto Guard animals survived.
The study's graphs make those differences especially clear.
Why Does Crypto Guard Calf Protection Matter?
Because managing the symptoms of scours isn't necessarily the same as addressing the Crypto challenge itself.
Supportive approaches may have a place in calf care, but Crypto Guard was developed specifically for C. parvum — and tested against it.
When you're evaluating a Crypto strategy, don't just ask what's commonly used.
Ask what's been put to the test.
Crypto Guard is the only product with actual calf challenge data supporting its claims.
Learn more about our animal studies.


Comments